Literature DB >> 31741769

Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma.

Rachel L G Maus1, James W Jakub2, Tina J Hieken2, Wendy K Nevala1, Trace A Christensen3, Shari L Sutor1, Thomas J Flotte4, Svetomir N Markovic1.   

Abstract

Epithelial tumors including melanoma often first metastasize to regional, sentinel lymph nodes (SLN). Thus, the presence of SLN metastases is a critical prognostic factor of survival. Prior to metastasis, accumulating evidence suggests the SLN is immunologically compromised; however, the process by which pre-metastatic niche formation occurs remains unknown. In this prospective study, freshly dissected, afferent lymphatic fluid was obtained during SLN biopsy in three patients with primary cutaneous melanoma. Lymphatic extracellular vesicles (L-EV) were visualized by transmission electron microscopy and proteomic cargo profiled by mass spectrometry. Flow cytometry assessed L-EV effects on autologous dendritic cell maturation in vitro. Immunogold electron microscopy and immunohistochemistry visualized expression of EV cargo within the primary tumor and SLN. Lymphatic extracellular vesicles from each afferent lymphatic channel demonstrated inhibition of autologous dendritic cell maturation. Proteomic profiling identified 81 peptides shared among the L-EV preparations including a signature of 18 immune-modulating proteins including previously established inhibitor of dendritic cell maturation, S100A9. Immunohistochemistry and immunogold electron microscopy confirmed S100A9 tracking along the lymphatic path, from keratinocytes in the primary tumor to sub-capsular macrophages in the SLN. Our findings suggest L-EV cargo may serve as early mediators of tumor-induced immune subversion in regional lymph nodes, by preceding malignant cells and trafficking within the lymphatic vasculature to harbor the first pre-metastatic niche.
© 2019 The Author(s). Published by Taylor & Francis.

Entities:  

Keywords:  dendritic cells; extracellular vesicles; lymphatic; pre-metastatic niche; sentinel lymph node

Year:  2019        PMID: 31741769      PMCID: PMC6844317          DOI: 10.1080/2162402X.2019.1667742

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  44 in total

1.  Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment.

Authors:  A J Cochran; D L Morton; S Stern; A M Lana; R Essner; D R Wen
Journal:  Mod Pathol       Date:  2001-06       Impact factor: 7.842

Review 2.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

3.  Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

Authors:  Donald L Morton; Alistair J Cochran; John F Thompson; Robert Elashoff; Richard Essner; Edwin C Glass; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; He-jing Wang
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

4.  Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes.

Authors:  Marcin Kowanetz; Xiumin Wu; John Lee; Martha Tan; Thijs Hagenbeek; Xueping Qu; Lanlan Yu; Jed Ross; Nina Korsisaari; Tim Cao; Hani Bou-Reslan; Dara Kallop; Robby Weimer; Mary J C Ludlam; Joshua S Kaminker; Zora Modrusan; Nicholas van Bruggen; Franklin V Peale; Richard Carano; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-16       Impact factor: 11.205

5.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

6.  Myeloid cell function in MRP-14 (S100A9) null mice.

Authors:  Josie A R Hobbs; Richard May; Kiki Tanousis; Eileen McNeill; Margaret Mathies; Christoffer Gebhardt; Robert Henderson; Matthew J Robinson; Nancy Hogg
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.

Authors:  Chao-Nan Qian; Bree Berghuis; Galia Tsarfaty; MaryBeth Bruch; Eric J Kort; Jon Ditlev; Ilan Tsarfaty; Eric Hudson; David G Jackson; David Petillo; Jindong Chen; James H Resau; Bin Tean Teh
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

8.  S100 chemokines mediate bookmarking of premetastatic niches.

Authors:  Shahin Rafii; David Lyden
Journal:  Nat Cell Biol       Date:  2006-12       Impact factor: 28.824

9.  Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation.

Authors:  Rachel L G Maus; James W Jakub; Wendy K Nevala; Trace A Christensen; Klara Noble-Orcutt; Zohar Sachs; Tina J Hieken; Svetomir N Markovic
Journal:  Front Immunol       Date:  2017-03-29       Impact factor: 7.561

10.  A novel and simple method for generation of human dendritic cells from unfractionated peripheral blood mononuclear cells within 2 days: its application for induction of HIV-1-reactive CD4(+) T cells in the hu-PBL SCID mice.

Authors:  Akira Kodama; Reiko Tanaka; Mineki Saito; Aftab A Ansari; Yuetsu Tanaka
Journal:  Front Microbiol       Date:  2013-09-27       Impact factor: 5.640

View more
  10 in total

Review 1.  Tumor-draining lymph nodes: At the crossroads of metastasis and immunity.

Authors:  Haley du Bois; Taylor A Heim; Amanda W Lund
Journal:  Sci Immunol       Date:  2021-09-03

Review 2.  The Regulation of Lymph Node Pre-Metastatic Niche Formation in Head and Neck Squamous Cell Carcinoma.

Authors:  Chen Hu; Qiang Huang; Qing Sun
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

Review 3.  Extracellular Vesicles as Potential Prognostic Markers of Lymphatic Dysfunction.

Authors:  Andreea Milasan; Maya Farhat; Catherine Martel
Journal:  Front Physiol       Date:  2020-05-25       Impact factor: 4.566

Review 4.  Tumor-Derived Extracellular Vesicles and the Immune System-Lessons From Immune-Competent Mouse-Tumor Models.

Authors:  Marvin Droste; Basant K Thakur; Brian P Eliceiri
Journal:  Front Immunol       Date:  2020-12-16       Impact factor: 7.561

Review 5.  Extracellular Vesicles: Novel Opportunities to Understand and Detect Neoplastic Diseases.

Authors:  Laura Bongiovanni; Anneloes Andriessen; Marca H M Wauben; Esther N M Nolte-'t Hoen; Alain de Bruin
Journal:  Vet Pathol       Date:  2021-04-05       Impact factor: 2.221

Review 6.  Mechanisms of extracellular vesicle-mediated immune evasion in melanoma.

Authors:  Lothar C Dieterich
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 7.  Antigen transfer and its effect on vaccine-induced immune amplification and tolerance.

Authors:  Yingying Shi; Yichao Lu; Jian You
Journal:  Theranostics       Date:  2022-08-01       Impact factor: 11.600

8.  Lymph Liquid Biopsy for Detection of Cancer Stem Cells.

Authors:  Mikyung Han; J Alex Watts; Azemat Jamshidi-Parsian; Urooba Nadeem; Eric R Siegel; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Cytometry A       Date:  2020-09-18       Impact factor: 4.714

Review 9.  Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles.

Authors:  Ihor Arkhypov; Samantha Lasser; Vera Petrova; Rebekka Weber; Christopher Groth; Jochen Utikal; Peter Altevogt; Viktor Umansky
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

Review 10.  The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells.

Authors:  Leila Asef-Kabiri; Hassan Yousefi; Reza Hosseini; Hamzeh Sarvnaz; Majid Salehi; Mohammad Esmaeil Akbari; Nahid Eskandari
Journal:  Mol Cancer       Date:  2021-06-02       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.